An exciting glimpse into the future when antibodies can be programmed
to have their Fv or Fab components crystallize upon release from the p
arental molecules is given here by Alien B. Edmundson and colleagues.
Targeted crystal packing surfaces remote from active sites can be mani
pulated without affecting the antigen-binding functions of the antibod
ies.